Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
MK-5046
Cat. No.:
OB0425LY-136
Appearance:
Solid
Purity:
99.6%
Identity:
Confirmed by LC-MS.
Size:
Add to basket
Product Overview
Description:
MK-5046 is a selective Bombesin receptor subtype-3 (BRS-3) allosteric agonist that inhibits food intake in mouse models.
Synonyms:
1022152-70-0; MK5046; (2S)-1,1,1-trifluoro-2-(4-pyrazol-1-ylphenyl)-3-[5-[[1-(trifluoromethyl)cyclopropyl]methyl]-1H-imidazol-2-yl]propan-2-ol; (2S)-1,1,1-Trifluoro-2-(4-(1H-pyrazol-1-yl)phenyl)-3-(4-((1-(trifluoromethyl)cyclopropyl)methyl)-1H-imidazol-2-yl)propan-2-ol; (S)-2-(4-(1H-pyrazol-1-yl)phenyl)-1,1,1-trifluoro-3-(5-((1-(trifluoromethyl)cyclopropyl)methyl)-1H-imidazol-2-yl)propan-2-ol; 1H-Imidazole-2-ethanol, a-[4-(1H-pyrazol-1-yl)phenyl]-a-(trifluoromethyl)-5-[[1-(trifluoromethyl)cyclopropyl]methyl]-, (aS)-
CAS No.:
1022152-70-0
Compound CID:
49871766
Formula:
C20H18F6N4O
Formula Weight:
444.37
Specification
Target:
Bombesin receptor
Pathway:
GPCR/G protein
Solubility:
DMSO
Storage:
Storage at -20°C.
Applications:
MK-5046 is commonly used in studies for the treatment of diabetes, obesity and other metabolic diseases.
